The Indian Council of Medical Research will review 3,000-5,000 people above 45 years of age, of which up to 80% will be those who have taken the AstraZeneca vaccine made locally by the Serum Institute of India. The rest will have taken Covaxin jointly developed by local firm Bharat Biotech and ICMR.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3yNTGBx
via IFTTT
0 comments:
Post a Comment